Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
OESOPHAGEAL CONDITIONS
Diagnostic testing
Wireless pH Capsule reflux testing:
Always follow the instructions specified by your physician or the nursing staff. Always follow the discharge instructions provided by your physician after your procedure.
STEP 01
Your physician will provide you with details of instructions to prepare for your test, beginning 7 days before the procedure. No eating or drinking 6 hours before your procedure.
Always follow the instructions specified by your physician or the nursing staff. Always follow the discharge instructions provided by your physician after your procedure.
STEP 02
Follow your usual daily routine. Don’t reduce or change your activities during the monitoring period. If you change things, the monitoring results aren’t as useful. Note: Don’t get the receiver wet because it’s not waterproof.
Always follow the instructions specified by your physician or the nursing staff. Always follow the discharge instructions provided by your physician after your procedure.
STEP 03
After the study has completed, you can resume your normal activities, diet and medications. The disposable pH capsule will detach and pass through the digestive tract in 7 to 10 days on average. Your physician will discuss the results of the monitoring test with you and develop a plan to manage your symptoms.
A small capsule, about the size of a gel cap, is temporarily attached to the wall of the oesophagus during an upper endoscopy. The capsule measures pH levels in the oesophagus and transmits readings to a receiver (about the size of a pager) worn on your belt or waistband.
Play our reflux heroes game to test your knowledge!
1 Richter J, Pandolfino J, Vela M, et al. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the Esophageal Diagnostic working Group. Disease of the Esophagus, 2012
2 Sweiss R et al. Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies. Aliment Pharmacol Ther. 2009 Mar 15;29(6):669-76. Page 673, Col 2
